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114 The Journal of Thoracic and Cardbjective: We sought to review the outcome of infants with a functional single
entricle receiving postoperative extracorporeal life support.
ethods: We reviewed all patients with a functional single ventricle receiving
ostoperative extracorporeal life support between January 1997 and May 2003.
esults: We supported 25 infants (age range, 2-139 days; median age, 15 days;
eight range, 1.9-5.9 kg; median weight, 3.4 kg) with extracorporeal life support.
perative procedures were Norwood stage 1 procedure in 18 patients, modified
lalock-Taussig shunt in 4 patients, bidirectional superior cavopulmonary shunt in
patients, and pulmonary vein repair in 1 patient. Indications for extracorporeal life
upport included cardiac arrest (14/25) and low cardiac output state (11/25). Extra-
orporeal membrane oxygenation was initiated in 19 patients, with conversion to a
entricular assist device in 7 patients. Ventricular assist device alone was initiated
n 6 patients. Survival to decannulation was 76%, with 5 late deaths from multiorgan
ailure and 56% intensive care unit survival. Survival to hospital discharge was
4%. On univariate analysis, the presence of arrhythmia before extracorporeal life
upport (P  .005), renal failure (P  .0007), Candida species–induced sepsis
P  .026), and multiorgan failure (P  .0009) were significant risk factors in the
onsurvivors. Median hospital stay was 43.5 days (range, 6-181 days) for the whole
roup and 93 days (range, 36-181 days) for survivors. Eight patients completed next
tage palliation.
onclusions: Twenty percent of patients were supported with a ventricular assist
evice alone, with 50% conversion to a ventricular assist device from extracorporeal
embrane oxygenation. Survival to decannulation was encouraging. Multiorgan
ailure and risk of invasive infection in the post–extracorporeal membrane oxygen-
tion period mitigate against survival to hospital discharge. Use of extracorporeal
ife support before cardiac arrest might reduce attrition between decannulation and
ospital discharge.
edical and surgical strategies for most neonates with a single functional
ventricle continue to evolve and improve. Extracorporeal life support
(ECLS) has been used successfully to salvage neonates with a functional
ingle ventricle from refractory low cardiac output syndrome postoperatively.1-7
ndeed, the elective use of ECLS to support patients after the Norwood stage 1
rocedure has been reported.5 We report our experience in a single tertiary pediatric
ardiac center with patients with a functional single ventricle who have been
upported with ECLS after palliative surgery.
We sought to review the outcomes of patients with a functional single ventricle
upported with ECLS postoperatively.
iovascular Surgery ● May 2006
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Dethods
e retrospectively reviewed all available clinical data, including
he hospital, surgical, and perfusion records, as well as, all echo-
ardiographic and angiographic studies. Autopsy data, if available,
ere reviewed.
Throughout the study period, we maintained a primed ECLS
ircuit with an oxygenator for rapid deployment, with the option to
onvert to a ventricular assist device (VAD) alone if suitable. In
ddition, an in-house team was assembled that was capable of
tarting a patient on ECLS at short notice. We used standard
ntibiotic coverage for the first 3 days after starting open-chest
CLS. We maintained strict surveillance for infection with daily
lood cultures; we did not use regular mediastinal washouts or
hange vascular lines routinely. We performed alternate-day cra-
ial ultrasonographic scans or sooner if clinical concern was
resent.
Data are described as frequencies, medians with ranges, and
eans with standard deviations. Comparison of categoric data was
erformed by using 2 or Fisher exact tests. Continuous data were
ompared by using t tests, paired t tests, and analysis of variance.
he Kruskal-Wallis test was used for nonparametric comparisons.
aplan-Meier “survival” curves were explored to compare “time-
o-event” rates. Log-rank tests were used to assess the statistical
ignificance. Statistics were analyzed by using a commercially
vailable software package (SAS version 8.2).
The research and ethics board of the Toronto Hospital for Sick
hildren approved the study.
esults
emographics, Diagnosis, and Operative Details
ata on demographics, diagnosis, and operative details are
hown in Table 1. From January 1997 through June 2003,
5 children (17 male and 8 female children) with a single
unctional ventricle were supported with ECLS after pallia-
ive surgery for a median of 112 hours (range, 13-240
ours). Median age was 15 days (range, 2-139 days), me-
ian weight was 3.5 kg (range, 1.9-5.9 kg), and median
estational age was 40 weeks (range, 32-41 weeks). Five
ere less than 37 weeks’ gestation, and 2 were less than 35
eeks’ gestation. Five patients had right atrial isomerism
RAI): 4 with obstructed total anomalous pulmonary venous
Abbreviations and Acronyms
ACT  activated clotting time
BT  Blalock-Taussig
ECLS  extracorporeal life support
ECMO  extracorporeal membrane oxygenation
ICU  intensive care unit
LCOS  low cardiac output state
RAI  right atrial isomerism
TAPVC total anomalous pulmonary venous
connection
VAD  ventricular assist deviceonnection (TAPVC), 3 with pulmonary atresia, 2 with t
The Journal of Thoraciculmonary stenosis, and 1 with additional subaortic steno-
is. All patients with RAI with obstructed TAPVC under-
ent repair with the sutureless technique with the use of in
itu pericardium.8 The Norwood stage 1 procedure was
erformed in 18 patients, of whom 3 had the Sano modifi-
ation with a right ventricle–to–pulmonary artery shunt.
CLS Details, Indications, Cause of Arrest, Time of
annulation, and Duration of ECLS
ata on ECLS details, indications, cause of arrest, time of
annulation, and duration of ECLS are shown in Table 2.
ECLS circuit. All patients were supported on a Bio-
edicus Portable Bypass System (Medtronic Perfusion
ystems) incorporating the centrifugal pump– based con-
ole and a water pump system. A prepackaged tubing set
ombined with an oxygenator, heat exchanger, constrained
ortex pump chamber, and flow probe was used to complete
he circuit. Pressure-, temperature-, and oxygen saturation–
onitoring devices enhanced the circuit. We used heparin-
onded (Carmeda) circuits (Medtronic Perfusion Systems).
he oxygenators were silicone membrane lungs (Medtronic
xtracorporeal membrane oxygenation [ECMO] oxygen-
tors; 13/20) or hollow-fiber Minimax oxygenators (7/20;
edtronic). We used Biomedicus, DLP (Medtronic), Jostra,
nd Polystan A/S cannulae. A modification of the same
ircuit without the oxygenator was used when adapted for
he VAD. ECLS was commenced in the operating room in
0 patients, on the basis of failure to wean from bypass in
patients and electively in 3 patients with RAI-TAPVC.
ourteen were cannulated in the cardiac intensive care unit
ICU) and 1 in the cardiac catheterization laboratory at a
edian time of 181 hours (range, 1-672 hours) after cardiac
urgery. Five were cannulated within 48 hours of surgical
ntervention. Cannulation was performed through an al-
eady open sternum in 21 patients, the sternum was opened
or cannulation in 3 patients, and cannulation was transcer-
ical in 1 patient. The indications for ECLS support were
ardiac arrest in 14 patients and low cardiac output state
LCOS) refractory to medical management in 11 patients.
e defined LCOS as a sustained mixed venous oxygen
aturation that remained less than 40% despite therapy.
he median duration of cardiac arrest was 36 minutes
range, 20-60 minutes). The cause of the cardiac arrest
as precipitated by poor myocardial function in 10 pa-
ients (of whom 5 had associated uncontrollable arrhyth-
ia) and by acute aortopulmonary shunt obstruction in 4
atients (1.9% of shunts performed during the study
eriod). Open chest cannulation was performed in all but
patient who was cannulated through the neck 16 days
fter surgical intervention. Two patients after superior
avopulmonary anastomosis were cannulated transter-
ally. A common atrial cannula was placed in one, and an
dditional cannula was placed in the innominate vein in
he other.
and Cardiovascular Surgery ● Volume 131, Number 5 1115
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DMode of ECLS support on initiation and subsequent
ourse. We initiated ECLS (ie, support with an oxygenator
n 19 patients and as a VAD without an oxygenator in 6
atients). In the former group the oxygenator was removed
rom the circuit in 7 patients after a median of 48 hours
range, 1-62 hours). Removal of the oxygenator from the
CLS circuit was not associated with mechanical compli-
ations. One patient who returned from the operating room
n VAD support required addition of the oxygenator in the
ABLE 1. Demographics, diagnosis, and operative details
atient no.
Age
(d)
Weight
(kg) Cardiac diagnosis
1 3 3.5 HLHS–Unbalanced AVSD Stage
co
2 4 3.6 HLHS with LV sinusoids Stage
co
3 9 3.0 Dextrocardia, LAI, TGA Stage
co
4 4 3.7 HLHS Stage
5 4 2.7 HLHS, Interrupted arch Stage
6 6 3.2 HLHS Stage
7 8 3.3 HLHS Stage
8 8 3.2 HLHS Stage
9 9 3.5 HLHS, AA Stage
10 14 4.3 HLHS Stage
11 15 3.1 TA, TGA Stage
12 17 3.2 HLHS Stage
13 21 1.9 HLHS Stage
14 28 2.4 HLHS, AA Stage
15 37 2.0 HLHS, AA Stage
16 42 3.8 HLHS Stage
17 112 4.9 HLHS Stage
18 139 4.8 DILV, TGA, Aortic
hypoplasia, MS
Stage
19 90 4.8 Dextrocardia, DOLV,
hypoplastic RV
DKS,
20 2 3.6 RAI, PA, AVSD,
obstructed TAPVD
Repa
TA
21 60 3.6 RAI, PA, AVSD,
obstructed TAPVD
Repa
TA
22 62 3.1 RAI, PA, TGA, AVSD,
obstructed TAPVD
Repa
TA
23 120 4.6 RAI, DORV, PS,
obstructed TAPVD
Repa
TA
24 120 5.9 RAI, DORV, AVSD,
subpulmonary stenosis,
subaortic stenosis
DKS,
25 15 2.6 PA, IVS, hypoplastic RV Right
PB, Cardiopulmonary bypass; ACC, aortic crossclamp; Circ A, circulator
efect; RV-PA, right ventricle to pulmonary artery; LV, left ventricle; LAI, le
A, tricuspid atresia; DILV, double-inlet left ventricle; MS, mitral stenosis; D
avopulmonary anastomosis; PA, pulmonary atresia; RAI, right atrial isomer
hunt; s/p, status post; DORV, double-outlet right ventricle; AVV, atrioventardiac critical care unit. The Blalock-Taussig (BT) shunt m
116 The Journal of Thoracic and Cardiovascular Surgery ● Maas clipped in 2 patients because of poor systemic perfu-
ion. The patients who received a BT shunt were managed
ith high flows (mean, 180  40 mL · kg1 · min1) and
fterload reduction with phenoxybenzamine, milrinone, or
oth. We aimed to maintain a normal arteriovenous oxygen
aturation difference with systemic oxygenation levels appro-
riate for a shunt-dependant patient. The patients who received
he Sano shunt were managed with mean flows of 150 
0 mL · kg1 · min1. Anticoagulation was maintained by
Operation
Shunt
size
CPB
(min)
ACC
(min)
Circ A
(min)
Hospital
survivor
orwood RV-PA 5.0 153 65 12 No
orwood RV-PA 5.0 145 65 14 Yes
orwood RV-PA 5.0 180 79 22 No
orwood 3.5 181 55 55 No
orwood 3.0 312 167 71 No
orwood 3.5 139 Yes
orwood 3.5 166 67 20 No
orwood 3.5 174 56 No
orwood 3.5 252 120 11 Yes
orwood 3.0 253 86 31 No
orwood 3.5 112 58 1 Yes
orwood, TV repair 3.5 155 37 1 Yes
orwood 3.0 135 60 No
orwood 3.5 227 75 3 No
orwood 3.0 171 76 Yes
orwood 3.5 138 79 Yes
orwood 4.0 437 233 Yes
orwood 4.0 206 76 1 Yes
A, PA plasty NA 332 18 No
obstructed
BTS, PA plasty
3.5 159 62 Yes
obstructed
s/p BTS
3.5 111 68 Yes
obstructed
BTS
3.5 109 60 52 No
obstructed
BCPA
NA 85 54 39 No
BTS, AVV repair 4.0 307 67 No
, PDA ligation 3.5 No
st; HLHS, hypoplastic left heart syndrome; AVSD, atrioventricular septal
ial isomerism; TGA, transposition of the great arteries; AA, aortic atresia;
double-outlet left ventricle; DKS, Damus-Kaye Stansel; BCPA, bidirectional
APVD, total anomalous pulmonary venous drainage; BTS, Blalock-Taussig
r valve; IVS, intact ventricular septum; PDA, patent ductus arteriosus.1 N
nduit
1 N
nduit
1 N
nduit
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
1 N
BCP
ir of
PVD,
ir of
PVD,
ir of
PVD,
ir of
PVD,
left
BTS
y arre
ft atr
OLV,
ism; Teans of continuous infusions of unfractionated heparin,
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Dhich were monitored on the basis of activated clotting
ime (ACT) and anti-Xa levels. Hourly ACT levels and
nti-Xa levels every 12 hours guided the management of
nticoagulation on ECLS. The target ACT levels for
CLS were 180 to 200 seconds and for VAD were 140 to
60 seconds with anti-Xa levels between 0.35 and 0.7
/mL. We found that monitoring of antithrombin 3 levels
nd the use of constant plasma infusions in small patients
mproved the effectiveness of our anticoagulation proto-
ABLE 2. ECLS details, indications, cause of arrest, time o
atient no. Cardiac diagnosis ECMO/VAD
Initia
of E
1 HLHS–Unbalanced
AVSD
Only ECMO OR
2 HLHS with LV sinusoids Only ECMO OR
3 Dextrocardia, LAI, TGA Only ECMO IC
4 HLHS Only ECMO OR
5 HLHS, IAA Only ECMO OR
6 HLHS Only ECMO IC
7 HLHS ECMO to VAD IC
8 HLHS ECMO to VAD OR
9 HLHS, AA Only VAD IC
10 HLHS ECMO to VAD IC
11 TA, TGA ECMO to VAD IC
12 HLHS Only ECMO IC
13 HLHS Only VAD IC
14 HLHS, AA Only ECMO IC
15 HLHS, AA ECMO to VAD IC
16 HLHS ECMO to VAD IC
17 HLHS VAD to ECMO OR
18 DILV, TGA, aortic
hypoplasia, MS
Only ECMO OR
19 Dextrocardia, DOLV,
hypoplastic RV
Only ECMO OR
20 RAI, PA, AVSD,
obstructed TAPVD
Only VAD OR
21 RAI, PA, AVSD,
obstructed TAPVD
Only VAD OR
22 RAI, PA, TGA, AVSD,
obstructed TAPVD
Only VAD IC
23 RAI, PS, DORV,
obstructed TAPVD
ECMO to VAD IC
24 RAI, DORV, AVSD,
subpulmonary
stenosis, subaortic
stenosis
Only ECMO IC
25 PA, IVS, hypoplastic RV Only ECMO CC
CMO, Extracorporeal membrane oxygenation; VAD, ventricular assist de
ypoplastic left heart syndrome; AVSD, atrioventricular septal defect; LCO
somerism; TGA, transposition of the great arteries; ICU, intensive care unit
tresia; DILV, double-inlet left ventricle; MS, mitral stenosis; PHT, pulmo
ulmonary atresia; TAPVD, total anomalous pulmonary venous drainage
entricular septum; CCL, cardiac catheterization laboratory.ol. We re-explored the mediastinum for bleeding, espe- t
The Journal of Thoracicially when the ACTs and anti-Xa levels were within the
arget range or there was associated hemodynamic insta-
ility. Cardiac catheterization was performed in 13 patients
upported with ECLS. We detected residual anatomic le-
ions in 3 patients (neoaortic obstruction, thrombosed BT
hunt, and precoronary obstruction in the native ascending
orta) and significant hemodynamic lesions in 2 patients
one with severe atrioventricular valve regurgitation and
ne with both atrioventricular and neoaortic regurgita-
nnulation, and duration of ECLS
Indication for ECLS
Time to ECLS
after OR (h)
Duration of
ECLS (h)
Hospital
survivor
LCOS NA 411 No
LCOS NA 95 Yes
CA 168 108 No
CA NA 17 No
LCOS NA 40 No
LCOS 30 13 Yes
CA 90 203 No
LCOS NA 175 No
CA 2 16 Yes
CA 216 198 No
Shunt obstruction 288 134 Yes
CA 216 120 Yes
CA 84 89 No
Shunt obstruction 672 104 No
Shunt obstruction 312 72 Yes
CA 384 96 Yes
LCOS NA 240 Yes
LCOS, PHT NA 58 Yes
LCOS NA 58 No
LCOS NA 96 Yes
LCOS NA 168 Yes
LCOS 12 192 No
CA 30 96 No
CA 1 136 No
Shunt obstruction 216 192 No
ECLS, extracorporeal membrane oxygenation; OR, operating room; HLHS,
cardiac output state; NA, not applicable; LV, left ventricle; LAI, left atrial
ardiac arrest; IAA, interrupted aortic arch; AA, aortic atresia; TA, tricuspid
hypertension; DOLV, double-outlet left ventricle; RV, right ventricle; PA,
, right atrial isomerism; DORV, double-outlet right ventricle; IVS, intactf ca
tion
CLS
U
U
U
U
U
U
U
U
U
U
U
U
U
U
L
vice;
S, low
; CA, c
nary
; RAIion). In 2 patients with RAI-TAPVC, cryoablation of
and Cardiovascular Surgery ● Volume 131, Number 5 1117
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Dbnormal conduction pathways was performed during
CLS.
omplications on ECLS
ignificant bleeding requiring surgical exploration occurred
n 20% of patients supported with a VAD compared with
5% of patients on full ECMO support. Renal failure (de-
ned as increased serum creatinine value above the standard
aboratory reference range for the relevant age group and
rine output of less than 1 mL · kg1 · h1) was present
n 16 (64%) of 25 patients. Peritoneal dialysis was per-
ormed in 9 patients, continuous venovenous hemofiltration
n 2 patients, and slow continuous ultrafiltration in 5 pa-
ients. Ten had sepsis (10/25 [40%]) with positive blood
ultures. Six (1 with Pseudomonas species and 5 with
ystemic Candida species infections) subsequently died.
dverse neurologic events occurred in 7 (28%) of 25
atients. Intracerebral hemorrhage identified by means of
ranial ultrasonography occurred in 3 patients (left parietal,
halamic, and intraventricular), cerebral infarcts were seen
n 2 patients, and 2 patients had seizures. Six of the 7 died
ubsequently. There were no neurologic complications in
he survivors supported with a VAD alone. Respiratory
omplications occurred in 3 patients who failed conversion to
AD, but all were decannulated and survived ICU discharge.
The overall median duration of mechanical ventilation
igure 1. The Kaplan-Meier survival curve for all patients sup-
orted with ECLS. The estimated overall survival is 38% (confi-
ence interval, 28%-50%) at 1000 days after ECLS support (dotted
ines), that for those supported electively is 48% (confidence
nterval, 31%-65%; single straight line), and that for those sup-
orted as rescue after cardiac arrest is 32% (confidence interval,
0%-47%; bold line). The actuarial overall survival at 1000 days
as 9 (36%) of 25 patients. On log-rank analysis, the increased
urvival in those supported electively was not statistically sig-
ificant (P  .17).as 504 hours (range, 144-2496 hours), and that in survi- s
118 The Journal of Thoracic and Cardiovascular Surgery ● Maors was 828 hours (range, 264-2496 hours). Three patients
ailed initial decannulation, 1 with LCOS and 2 with ar-
hythmia and subsequent LCOS; all 3 were resupported on
CMO, 1 was bridged to transplantation, and 2 died later, both
f whom were unsuitable candidates for transplantation.
AI-TAPVC Subgroup
ive infants with complex RAI (median age, 62 days; range,
-120 days; median weight, 3.6 kg; range, 3.1-5.9 kg) were
upported on ECLS. Three were supported electively on a
AD for a median duration of 168 hours (range, 96-192
ours). Two were supported on ECMO as rescue after
ardiac arrest. Two underwent cryoablation during ECLS
or refractory tachyarrhythmias. The 2 supported after car-
iac arrest died, and those supported electively were dis-
harged from the critical care unit. One was an expremature
aby with complex medical issues who died before hospital
ischarge.
CU, Hospital Survival, and Overall Survival Until the
nd of the Study
ata on ICU, hospital survival, and overall survival until the
nd of study are shown in Figure 1. Overall, 19 (75%) of 25
atients survived decannulation from mechanical support.
n 6 patients ECLS support was withdrawn. None of these
patients recovered cardiac function, and their course was
omplicated by intractable arrhythmias in 2 patients, mul-
iorgan failure in 2 patients, and systemic fungal infection in
 patients (Tables 3 and 4). The average duration of ECLS
n this group was 181 hours. Five died after decannulation
fter a median of 9 days (range, 5-23 days) after decannu-
ation, all with multiorgan failure complicated by systemic
nfection in 4 (Pseudomonas species in 1 and Candida
ABLE 3. Pre-ECLS, ECLS, and post-ECLS variables and
ospital survival
ariable
Hospital
survivor
(n  11)
Hospital
nonsurvivor
(n  14)
P
value
ardiac arrest 5/11 (45%) 9/14 (64%) .3464
rrhythmia before ECLS 0/11 (0%) 7/14 (50%) .0057*
hunt open 11/11 (100%) 2/14 (14%) .1742
xygenator not present
or removed
7/11 (58%) 6/14 (42%) .3019
ore than 120 h on ECLS 3/11 (27%) 7/14 (50%) .4954
enal failure 3/11 (27%) 13/14 (92%) .0007*
epsis 4/11 (36%) 6/14 (42%) .7422
andida species–induced
sepsis
0/11 (0%) 5/14 (35%) .0267*
ultiorgan failure (2) 0/11 (0%) 9/14 (64%) .0009*
rrhythmia after ECLS 1/11 (9%) 6/14 (42%) .0620
CLS, Extracorporeal life support. *Significant difference at P .05.pecies in 3) and impaired pulmonary blood flow related to
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Dthrombosed shunt in 1 patient. Fourteen patients were
ischarged from the cardiac critical care unit (survival rate
f 56%). Three died after discharge from the cardiac critical
are unit but before discharge from the hospital, 1 with RAI
ho had sepsis after line-related thrombus, 1 with hypo-
lastic left heart syndrome with severe neurologic impair-
ent, and 1 with hypoplastic left heart syndrome with
entral core myopathy, aqueduct stenosis, and increased
ntracranial pressure. The median duration of critical care
nit stay of survivors was 50 days (range, 12-120 days), and
hat in nonsurvivors was 18 days (range, 6-32 days). The
edian duration of hospital stay in the group who survived
o hospital discharge was 97 days (range, 36-181 days).
urvival to hospital discharge was 44%.
The median follow-up in this series has been 27 months
range, 7-50 months). Two patients died 3 months after initial
ospital discharge, 1 with decreased ventricular function
nd progressive pulmonary vein stenosis and 1 with poor
entricular function after bidirectional superior cavopulmo-
ary anastomosis. Among the 9 survivors to date, 8 have
ompleted second-stage palliation, and 1 has undergone
ardiac transplantation. A Kaplan-Meier survival curve was
onstructed to examine the estimated overall survival (Fig-
re 1). The estimated overall survival at 1000 days since
CLS was 38%, whereas the actuarial overall survival was
(36%) of 25 patients. On log-rank analysis, the increased
urvival in those supported electively was not statistically
ignificant (P  .17).
iscussion
his is the first review of ECLS in children after the staged
ABLE 4. Pre-ECLS, ECLS, and post-ECLS variables
nd survival
ariable
Hospital
survivor
(n  11),
median (range)
Hospital
nonsurvivor
(n  14),
median (range)
P
value
ge (d) 17 (2-139) 15 (3-120) .5694
eight (kg) 3.6 (2-4.9) 3.2 (1.9-5.9) .1741
PB (min) 155 (111-437) 180 (85-332) .2289
ortic crossclamp (min) 72 (37-233) 65 (18-167) .2940
irculatory arrest (min) 1 (1-14) 31 (3-71) .0072*
ime to cannulation
after operation (h)
252 (2-384) 90 (1-672) .2207
uration of cardiac
arrest (min)
40 (29-45) 35 (20-60) .5909
actate level before
ECLS
9 (2-21) 11 (2-24) .2905
uration of ECLS (h) 96 (13-240) 122 (17-411) .3118
CLS, Extracorporeal life support; CPB, cardiopulmonary bypass. *Signif-
cant difference at P .05.ingle-ventricle palliation, including Norwood stage 1 pro- N
The Journal of Thoracicedure, bidirectional cavopulmonary anastomosis, and re-
air of obstructed pulmonary veins in complex RAI. This
eview, although a single-center experience, supports pre-
ious reports that ECLS, with and without an oxygenator,
alvages some patients with a functional single ventricle in
he immediate postoperative period. We found that one fifth
f patients could be supported with a VAD alone, and nearly
alf were converted to a VAD from ECMO, which might
educe the complications associated with a membrane oxy-
enator. The risks of bleeding leading to exploration were
onsiderably less compared with those seen in patients
upported with ECMO. However, we were unable to show
mproved survival or freedom from organ dysfunction with
he use of a VAD alone compared with ECMO. We spec-
late that with larger numbers of patients the combination of
educed hemorrhage, blood product use, and the advantage
f a clinical substrate that tolerates support with a VAD
ight improve survival. Effective mechanical support could
e provided without the use of the oxygenator while keep-
ng the aortopulmonary shunt open and maintaining high
ump flows. Clipping the shunt was unnecessary, and the 2
atients who had the shunt clipped died. This is comparable
ith other reports in the literature showing that survival is
igher if the shunt is left open.4,9 Support with a VAD
ppeared to be most effective for isolated ventricular dys-
unction with adequate oxygenation.
The outcome of patients with right isomerism with or
ithout obstructed abnormal pulmonary venous drainage is
niformly poor.10-12 The elective use of VAD support in
his group of infants might have a role to play in the
mmediate postoperative period. However, improving early
nd midterm outcomes for this complex group of patients is
hallenging, and there continues to be high morbidity and
ortality.
In the current cohort of patients, we found that the
edian time of acute deterioration leading to cardiac arrest
nd ECLS support was 181 hours, which is 7.5 days after
urgical intervention. This highlights that the vulnerable
ritical period after surgical intervention is not limited to the
rst 24 to 48 hours, as reported previously. Wright and
olleagues13 reported that a dangerous increase in systemic
ascular resistance could occur remote from the initial op-
ration. In our experience afterload reduction is crucial in
he early postoperative management after the traditional
tage 1 Norwood procedure (BT shunt), and continued
fterload reduction therapy might be required to prevent late
ardiovascular collapse.14
Among the pre-ECLS variables, severe refractory tachy-
ysrhythmia as a reflection or cause of poor ventricular
unction was a significant predictor of poor survival. The
ombination of LCOS and negative inotropic drugs used to
ontrol the tachydysrhythmia are poorly tolerated after the
orwood stage 1 procedure. Early support of patients with
and Cardiovascular Surgery ● Volume 131, Number 5 1119
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1
CH
Dtachydysrhythmia with ECLS might permit rhythm con-
rol before cardiac arrest. The tendency for survival was
igher if ECLS was initiated electively (55% vs 36%), but
his was not statistically significant. Jaggers and associates9
ound almost 100% mortality if ECMO was instituted dur-
ng cardiac arrest. Timely institution of support can limit
nd-organ damage. Morbidity, mainly caused by multiorgan
ailure and sepsis after decannulation, however, is a signif-
cant problem resulting in long intensive care and hospital
tays and significant time-related attrition. In this cohort
ultiorgan failure and sepsis contributed to significant mor-
idity. More than half of the patients in this series were
upported on ECLS after cardiac arrest, which can increase
he risks of multiorgan failure. We found that multiple organ
ystem failure (defined as the failure of at least 2 organ
ystems,15 P  .0009) and renal failure (P  .0007) in
articular were significant risk factors for death among the
onsurvivors. Many studies have shown that renal failure is an
ndependent factor predisposing to increased mortality.3,4,9,16
n this study, although the decannulation from ECLS was
ncouraging, particularly in the high-risk subgroup with
AI-TAPVC, the attrition from the time of decannulation to
ospital discharge was a major issue. The median overall
urvival to hospital discharge for patients with a single
entricle supported on ECLS in the reported literature is
0% (range, 33%-64%).2,4,6,9,17-21 Our results compare fa-
orably at 44%. In our study the tendency for survival was
igher when a VAD alone was used (60% vs 40%) and if
he duration of ECLS was less than 120 hours (72% vs
0%), but this was not statistically significant. The rela-
ively small number of patients and the retrospective design
f the study preclude use of multivariate analysis.
In a multivariate analysis of risk factors for operative
utcome for stage 1 operations in 158 patients, Gaynor and
olleagues18 identified that ECLS support was one of the
redictors of operative mortality (P  .001). In a recent
tudy from the same institution reviewing the outcome of all
atients supported with ECLS over a 5-year period,6 single-
entricle physiology and failure to separate from cardiopul-
onary bypass were not associated with an increased risk of
ortality. The factors identified that increased the probabil-
ty of mortality in postoperative patients were age less than
month, male sex, longer duration of mechanical ventila-
ion before ECLS, and development of renal or hepatic
ysfunction during ECLS. Continuing multiorgan failure,
nfection, and thrombosis in the post-ECLS phase are risk
actors for prolonged critical care unit stay, hospital stay,
nd late mortality. Montgomery and coworkers,22 in their
eview of 59 children treated with ECMO after cardiopul-
onary bypass over a 9-year period, reported that progres-
ive multiple organ system dysfunction and development of a
osocomial infection were significantly associated with death.
120 The Journal of Thoracic and Cardiovascular Surgery ● Mahis warrants aggressive management of LCOS, anticoagula-
ion, and treatment and prevention of systemic infections.
The Extracorporeal Life Support Organization Registry has
eported data over a 4-year period from 1996 through 2000
ocumenting the substantial increase in neonatal ECLS. Sur-
ival rates have remained constant at 35%.23 However,
urvival rates in the disadvantaged patients with a single
entricle was not significantly lower than in the biventricu-
ar group of cardiac patients.
There is no doubt that in a small subset of patients after
unctional single-ventricle palliation, use of ECLS posi-
ively affects survival. Thus ECLS will remain an important
esource, albeit highly technical and expensive, when faced
ith adverse hemodynamics in the immediate postoperative
eriod. With further advances in the surgical management
f hypoplastic left and right heart syndrome, optimum
CLS support in the initial postoperative period will be an
mportant treatment option until identification of residual
orrectable lesions and recovery of the stressed myocar-
ium. The long-term neurologic morbidity is significant,24,25
nd survivors might have cognitive impairment, motor impair-
ent, or both and require prolonged care, with major implica-
ions on health care resources.26
A second run of ECLS carried a high mortality. How-
ver, it was difficult to predict which patients might benefit
ithout recourse to transplantation.
We identified that longer periods of circulatory arrest are
ssociated with reduced survival (Table 4). We suggest that
echniques to limit prolonged periods of total circulatory
rrest by providing regional perfusion might be important
eterminants of short-term outcome.
Early identification, recognition, and management of
COS is crucial because early use of ECLS before cardiac
rrest when LCOS is present, especially in the presence of
tachydysrhythmia, might reduce the morbidity related to
ultiorgan failure between decannulation and hospital dis-
harge. Strategies to improve survival to hospital discharge
re required to justify the continued use of ECLS in this
atient group, especially as critical care unit and hospital
tays are prolonged.
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